On ECHEMI
Home > Drugs > CSPC OUYI Pharmaceutical Co., Ltd.
CSPC OUYI Pharmaceutical Co., Ltd.
  • Founded in:

    2001-03-29
  • Country:

    China China
  • Address:

    No. 88, Yangzi Road, Shijiazhuang Economic and Technological Development Zone
  • Tax NO.:

    91130100601289268L
  • Registered Funds:

    298 million yuan
  • Website:

  • Email:

Related Drugs
Heat-clearing and detoxifying soft capsules
Gypsum, honeysuckle, Scrophularia, Rehmannia, Forsythia, Gardenia, Sweet Peony, Scutellaria, Gentiana, Isatis, Anemarrhena, Ophiopogon, etc.
Name Description Content CAS NO. Registered Holders
Calcium sulfate dihydrate

10101-41-4 0
LONICERAE JAPONICAE FLOS

0
Scrophulariae Radix

0
Rehmannia

0
Forsythiae Fructus

0
Gardeniae Fructus

0
sweet diced

0
RADIX SCUTELLARIAE

0
Borneol

507-70-0 1
Isatidis Radix

0
ANEMARRHENAE RHIZOMA

0
Ophiopogonis Radix

0
Heat-clearing and detoxifying soft capsules
Gypsum, honeysuckle, Scrophularia, Rehmannia, Forsythia, Gardenia, Sweet Herb, Scutellaria, Gentiana, Isatis, Anemarrhena, Ophiopogon.
Name Description Content CAS NO. Registered Holders
Calcium sulfate dihydrate

10101-41-4 0
LONICERAE JAPONICAE FLOS

0
Scrophulariae Radix

0
REHMANNIAE RADIX PRAEPARATA

0
Forsythiae Fructus

0
Gardeniae Fructus

0
sweet diced

0
RADIX SCUTELLARIAE

0
Borneol

507-70-0 1
Isatidis Radix

0
ANEMARRHENAE RHIZOMA

0
Ophiopogonis Radix

0
Aspirin enteric-coated tablets
Aspirin. Chemical name: 2-(acetoxy)benzoic acid, molecular formula: C9H8O4, molecular weight: 180.2
Name Description Content CAS NO. Registered Holders
Acetylsalicylic acid

This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects

More

This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects

50-78-2 35
Levofloxacin Hydrochloride Capsules
The main ingredient of this product is levofloxacin hydrochloride. Its chemical name is (S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H pyrido[1,2,3-de]-[1,4]benzo[omicron]oxazine-6-carboxylic acid hydrochloride hydrate.
Name Description Content CAS NO. Registered Holders
Levofloxacin hydrochloride

This product has a broad-spectrum antibacterial effect and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae, such as Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, and Gram-negative bacteria such as Haemophilus influenzae, Legionella pneumophila, and Neisseria gonorrhoeae. It also has antibacterial effects on Gram-positive bacteria such as Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, and Mycoplasma pneumoniae and Chlamydia pneumoniae, but has poor effects on anaerobic bacteria and enterococci. Its mechanism of action is to inhibit the activity of bacterial DNA gyrase, prevent the synthesis and replication of bacterial DNA, and cause bacterial death.

More

This product has a broad-spectrum antibacterial effect and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae, such as Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, and Gram-negative bacteria such as Haemophilus influenzae, Legionella pneumophila, and Neisseria gonorrhoeae. It also has antibacterial effects on Gram-positive bacteria such as Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, and Mycoplasma pneumoniae and Chlamydia pneumoniae, but has poor effects on anaerobic bacteria and enterococci. Its mechanism of action is to inhibit the activity of bacterial DNA gyrase, prevent the synthesis and replication of bacterial DNA, and cause bacterial death.

177325-13-2 18
Rivaroxaban Tablets
The main ingredient of this product is rivaroxaban. Chemical name: 5-chloro-nitrogen-({(5S)-2-oxo-3-[-4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophene-carboxamide Chemical structure: Molecular formula: C19H18ClN3O5S Molecular weight: 435.89
Name Description Content CAS NO. Registered Holders
Rivaroxaban

Extract the name, type (main ingredient or excipient), content, unit, and pharmacological action of the raw material from the above information

More

Extract the name, type (main ingredient or excipient), content, unit, and pharmacological action of the raw material from the above information

366789-02-8 143
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.